A strength of the interactionist approach to treatment is that it is supported by a randomised, controlled trial conducted by guo et al, which found combining medication and therapy is more effective at treating schizophrenia than just using medication. However, a limitation is that combining treatments is an expensive option but it could be argued this is cost-effective because patients are less likely to relapse and more likely to return to work.